Cargando…

The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia

BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment out...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Tomohiro, Mizokami, Fumihiro, Fukami, Kazuhiro, Ito, Kazuhiro, Shibasaki, Masataka, Nagamatsu, Tadashi, Furuta, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793010/
https://www.ncbi.nlm.nih.gov/pubmed/24109180
http://dx.doi.org/10.2147/CIA.S52259
_version_ 1782286920720580608
author Mizuno, Tomohiro
Mizokami, Fumihiro
Fukami, Kazuhiro
Ito, Kazuhiro
Shibasaki, Masataka
Nagamatsu, Tadashi
Furuta, Katsunori
author_facet Mizuno, Tomohiro
Mizokami, Fumihiro
Fukami, Kazuhiro
Ito, Kazuhiro
Shibasaki, Masataka
Nagamatsu, Tadashi
Furuta, Katsunori
author_sort Mizuno, Tomohiro
collection PubMed
description BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment outcome of VCM remains unknown. OBJECTIVE: To elucidate the association between severe hypoalbuminemia and VCM treatment outcomes, we examined pharmacokinetic/pharmacodynamic (PK/PD) parameters in elderly patients with severe hypoalbuminemia. METHODS: We conducted a retrospective observational study of 94 patients with methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired pneumonia who had been treated with VCM between January 2006 and December 2012. The 94 patients were divided into severe hypoalbuminemia and non-severe hypoalbuminemia groups. The PK/PD parameters and treatment outcomes of VCM were compared between the two groups. RESULTS: The half-life of VCM in the severe hypoalbuminemia group was significantly longer than in the non-severe hypoalbuminemia group (33.2 + 5.4 vs 24.9 + 1.6; P = 0.049). Area under the concentration curve (AUC)/minimum inhibitory concentration (MIC) values of 250–450 and >450 μg × h/mL were significantly associated with 28-day mortality in the severe hypoalbuminemia group (P < 0.001), whereas AUC/MIC values of <250 μg × h/mL were not associated. We also detected a significant difference in the increased percentage of nephrotoxicity in the severe hypoalbuminemia group (6 of 23 patients [26%]) compared with the non-severe hypoalbuminemia group (6 of 71 patients [8%]; P < 0.001). CONCLUSION: These findings indicate that severe hypoalbuminemia influences the half-life of VCM and treatment outcomes in elderly patients (≥75 years of age). To establish a more effective and safer treatment protocol, the issue of malnutrition in elderly patients needs to be addressed and improved.
format Online
Article
Text
id pubmed-3793010
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37930102013-10-09 The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia Mizuno, Tomohiro Mizokami, Fumihiro Fukami, Kazuhiro Ito, Kazuhiro Shibasaki, Masataka Nagamatsu, Tadashi Furuta, Katsunori Clin Interv Aging Original Research BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment outcome of VCM remains unknown. OBJECTIVE: To elucidate the association between severe hypoalbuminemia and VCM treatment outcomes, we examined pharmacokinetic/pharmacodynamic (PK/PD) parameters in elderly patients with severe hypoalbuminemia. METHODS: We conducted a retrospective observational study of 94 patients with methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired pneumonia who had been treated with VCM between January 2006 and December 2012. The 94 patients were divided into severe hypoalbuminemia and non-severe hypoalbuminemia groups. The PK/PD parameters and treatment outcomes of VCM were compared between the two groups. RESULTS: The half-life of VCM in the severe hypoalbuminemia group was significantly longer than in the non-severe hypoalbuminemia group (33.2 + 5.4 vs 24.9 + 1.6; P = 0.049). Area under the concentration curve (AUC)/minimum inhibitory concentration (MIC) values of 250–450 and >450 μg × h/mL were significantly associated with 28-day mortality in the severe hypoalbuminemia group (P < 0.001), whereas AUC/MIC values of <250 μg × h/mL were not associated. We also detected a significant difference in the increased percentage of nephrotoxicity in the severe hypoalbuminemia group (6 of 23 patients [26%]) compared with the non-severe hypoalbuminemia group (6 of 71 patients [8%]; P < 0.001). CONCLUSION: These findings indicate that severe hypoalbuminemia influences the half-life of VCM and treatment outcomes in elderly patients (≥75 years of age). To establish a more effective and safer treatment protocol, the issue of malnutrition in elderly patients needs to be addressed and improved. Dove Medical Press 2013 2013-09-30 /pmc/articles/PMC3793010/ /pubmed/24109180 http://dx.doi.org/10.2147/CIA.S52259 Text en © 2013 Mizuno et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mizuno, Tomohiro
Mizokami, Fumihiro
Fukami, Kazuhiro
Ito, Kazuhiro
Shibasaki, Masataka
Nagamatsu, Tadashi
Furuta, Katsunori
The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title_full The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title_fullStr The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title_full_unstemmed The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title_short The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
title_sort influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant staphylococcus aureus hospital-acquired pneumonia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793010/
https://www.ncbi.nlm.nih.gov/pubmed/24109180
http://dx.doi.org/10.2147/CIA.S52259
work_keys_str_mv AT mizunotomohiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT mizokamifumihiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT fukamikazuhiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT itokazuhiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT shibasakimasataka theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT nagamatsutadashi theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT furutakatsunori theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT mizunotomohiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT mizokamifumihiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT fukamikazuhiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT itokazuhiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT shibasakimasataka influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT nagamatsutadashi influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia
AT furutakatsunori influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia